Bayer CropScience (506285) Q4 24/25 earnings summary

Executive summary

• Audited financial results for the year ended March 31, 2025, were approved with an unmodified audit opinion from Deloitte Haskins & Sells LLP.

• The Board of Directors recommended a final dividend of ₹35 per share, totaling ₹1,573 million.

Financial highlights

• Revenue from operations for FY25 was ₹54,734 million, up from ₹51,062 million year-over-year.

• Net profit for FY25 was ₹5,680 million, compared to ₹7,405 million in FY24.

• EBITDA and operating profit declined, with profit before tax at ₹7,074 million versus ₹9,414 million last year.

• Earnings per share for FY25 stood at ₹126.38, down from ₹164.77 in FY24.

Outlook and guidance

• The business is seasonal, and quarterly figures are not necessarily indicative of full-year performance.

• The Board recommended a final dividend, reflecting confidence in the company’s financial position.